Clinical laboratory International (CLI)
The leading international magazine for Clinical laboratory Equipment for everyone in the in vitro diagnostics field and related disciplines.
https://clinlabint.com/wp-content/uploads/sites/2/2023/05/Ziathpr56.jpg
1359
1920
panglobal
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png
panglobal2023-05-26 12:51:082023-05-26 12:53:35Ziath’s new RFID tagging technology streamlines cryogenic sample management
Gilead Sciences announces positive results from Veklury and obeldesivir trials
, /in Featured Articles /by panglobalGilead Sciences announces positive results from Veklury and obeldesivir trials Gilead Sciences, announced positive results from several COVID-19 clinical and real-world evidence studies presented at ECCMID. A Phase 3 clinical study demonstrated that Veklury (remdesivir) was generally well tolerated in people with moderate to severe renal impairment. Additional data includes a retrospective real-world study which […]
Axcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue
, /in Featured Articles /by panglobalAxcella Therapeutics presents results from Phase 2a clinical trial of AXA1125 for treatment of Long COVID Fatigue Axcella Therapeutics – a clinical-stage biotechnology company pioneering novel approaches to treating complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions – gave two oral presentations of results from the Phase 2a clinical trial of AXA1125 in the […]
Shionogi demonstrates efficacy of cefiderocol against difficult-to-treat Gram-negative bacterial infections
, /in Featured Articles /by panglobalShionogi demonstrates efficacy of cefiderocol against difficult-to-treat Gram-negative bacterial infections At ECCMID 2023, Osaka, Japan-based Shionogi announced key data for cefiderocol, an innovative siderophore cephalosporin, including new real-world evidence demonstrating its efficacy against some of the most difficult-to-treat Gram-negative bacterial infections.
ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics
, /in Featured Articles /by panglobalELITech showcases new high throughput sample-to-result instrument for molecular diagnostics Also at ECCMID, ELITech Group unveiled the upcoming launch of a new high throughput sample-to-result instrument for molecular diagnostics.